Synergistic effect of immunization with a peptide cocktail including antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus

Journal of General Virology

Volumn 80, Issue 6, 1999, Pages 1401-1405

  Hsu, S C ^a   Chargelegue, D ^a,b   Obeid, O E ^a,c   Steward, M W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

ANIMALIA; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SYNCYTIAL VIRUS;

EID: 0032977751     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-6-1401     Document Type: Article

References (25)

1. Alwan, W. H., Record, F. M. & Openshaw, P. J. (1992). CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells. Clinical and Experimental Immunology 88, 527-536.
2. Bachmann, M. F., Kalinke, U., Althage, A., Freer, G., Burkhart, C., Roost, H. P., Aguet, M., Hengartner, H. & Zingernagel, R. M. (1997). The role of antibody concentration and avidity in antiviral protection. Science 276, 2024-2027.
3. Cannon, M. J., Stott, E. J., Taylor, G. & Askonas, B. A. ( 1987). Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology 62, 133-138.
4. Chargelegue, D., Obeid, O. E., Hsu, S. C., Shaw, M. D., Denbury, A. N., Taylor, G. & Steward, M. W. (1998). A peptide mimic of a protective epitope of respiratory syncytial virus selected from a combinatorial library induces virus-neutralizing antibodies and reduces viral load in vivo. Journal of Virology 72, 2040-2046.
5. Chin, J., Magoffin, R. L., Shearer, L. A., Schieble, J. H. & Lennette, E. H. (1969). Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. American Journal of Epidemiology 89, 449-463.
6. Connors, M., Collins, P. L., Firestone, C. Y. & Murphy, B. R. (1991). Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. Journal of Virology 65, 1634-1637.
7. Connors, M., Kulkarni, A. B., Firestone, C. Y., Holmes, K. L., Morse, H. C., III, Sotnikov, A. V. & Murphy, B. R. (1992). Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. Journal of Virology 66, 7444-7451.
8. Crowe, J. E., Jr, Bui, P. T., Davis, A. R., Chanock, R. M. & Murphy, B. R. (1994). A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immuno-genicity and protective efficacy against wild-type challenge in sero-negative chimpanzees. Vaccine 12, 783-790.
9. Fulginiti, V. A., Eller, J. J., Sieber, O. F., Joyner, J. W., Minamitani, M. & Meiklejohn, G. (1969). Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. American Journal of Epidemiology 89, 435-448.
10. Gaddum, R. M., Cook, R. S., Wyld, S. G., Lopéz, J. A., Bustos, R., Melero, J. A. & Taylor, G. (1996). Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection. Journal of General Virology 77, 1239-1248.
11. Graham, B. S., Bunton, L. A., Wright, P. F. & Karzon, D. T. (1991). Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. Journal of Clinical Investigation 88, 1026-1033.
12. Groothuis, J. R., Simoes, E. A., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C. and others (1993). Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. New England Journal of Medicine 329, 1524-1530.
13. Hall, C. B. (1994). Prospects for a respiratory syncytial virus vaccine. Science 265, 1393-1394.
14. Heilman, C. A. (1990). From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses. Journal of Infectious Diseases 161, 402-406.
15. Hsu, S. C., Chargelegue, D. & Steward, M. W. (1998). Reduction of respiratory syncytial virus titer in the lungs of mice after intranasal immunization with a chimeric peptide consisting of a single CTL epitope linked to a fusion peptide. Virology 240, 376-381.
16. Kulkarni, A. B., Collins, P. L., Bacik, I., Yewdell, J. W., Bennink, J. R., Crowe, J. E., Jr & Murphy, B. R. (1995). Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. Journal of Virology 69, 1261-1264.
17. Openshaw, P. J., Clarke, S. L. & Record, F. M. (1992). Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. International Immunology 4, 493-500.
18. Prince, G. A., Hemming, V. G., Horswood, R. L. & Chanock, R. M. (1985). Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Research 3, 193-206.
19. Rodriguez, F., Zhang, J. & Whitton, J. L. (1997). DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. Journal of Virology 71, 8497-8503.
20. Sparer, T. E., Matthews, S., Hussell, T., Rae, A. J., Garcia-Barreno, B., Melero, J. A. & Openshaw, P. J. (1998). Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. Journal of Experimental Medicine 187, 1921-1926.
21. Speidel, K., Osen, W., Faath, S., Hilgert, I., Obst, R., Braspenning, J., Momburg, F., Hammerling, G. J. & Rammensee, H. G. (1997). Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses. European Journal of Immunology 27, 2391-2399.
22. Srikiatkhachorn, A. & Braciale, T. J. (1997). Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. Journal of Experimental Medicine 186, 421-432.
23. Trudel, M., Nadon, F., Seguin, C., Brault, S., Lusignan, Y. & Lemieux, S. (1992). Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine. Vaccine 10, 107-112.
24. Walsh, E. E. (1994). Humoral, mucosal, and cellular immune response to topical immunization with a subunit respiratory syncytial virus vaccine. Journal of Infectious Diseases 170, 345-350.
25. Wertz, G. W. & Sullender, M. W. (1992). Approaches to immunization against respiratory syncytial virus. In Vaccines: New Approaches to Immunological Problems, pp. 151-176. Edited by R. W. Eltis. Boston: Butterworth-Heinemann.